SaveRxCanada.to, a trusted international online pharmacy, is helping U.S. patients save thousands of dollars on the lung cancer drug Tagrisso by partnering with licensed suppliers in India. By providing access to the medication at significantly reduced prices, patients can save up to $5,500 USD per month, resulting in potential annual savings of over $66,000 USD. This allows patients to afford the targeted therapy, which offers improved survival outcomes and quality of life for those with non-small cell lung cancer (NSCLC) with EGFR mutations. SaveRxCanada.to ensures the safety, authenticity, and efficacy of the medication from licensed international suppliers.